龙沙Lonza在哺乳动物细胞表达技术上拥有超过35年的开发经验,其Lonza GS Xceed® Expression System作为全球知名的GS-CHO蛋白表达系统,凭借经验证的专业技术,能够快速构建可靠、高产的CHO细胞株,优化蛋白表达,用于商业化生产包括单克隆抗体在内的新一代生物药,并缩短产品上市时间,满足市场对新型生物药不断增长的需求。
产品名称 Lonza GS Xceed基因表达系统 用途范围 蛋白表达 是否进口 是 加工定制 是 品牌中文 龙沙 产地 瑞士 组成 宿主细胞、载体、技术等 宿主细胞 GS Xceed CHOK1SV GS-KO 载体 GSquad载体、GSquad恒定区载体、GS位点特异性偶联载体 内容 载体构建、细胞株开发、法规支持等 培养基 GSv9培养基和补料...
POTELLIGENT_CHOK1SV Potelligent® CHOK1SV
CHOKISV, developed by Lonza Biologies, is a suspension, protein-free-adapted CHOKl-derivative utilizing the glutamine synthetase (GS) gene expression system. CHOKISV expresses the GS enzyme endogenously; thus, positive transfectants were obtained under the dual selection of methionine sulfoximine (MSX...
The licensed cell line combines BioWa's engineered glycosylation Potelligent Technology with Lonza's GS Gene Expression System. BioWa, Inc. and Lonza have entered intoresearch agreements with Pfizer allowing the use of the Potelligent CHOK1SV Cell Line in the research and development of multiple ...
Lonza and BioWa Sign License Agreements with Pfizer, Inc. Allowing Use of Their POTELLIGENT® CHOK1SV Cell Line for Therapeutic Antibody Research and Development
A range of concentrations was then added to CHO cells, along with MSX, during cell pool construction using Lonza's CHOK1SV GS-KO? proprietary host cell line to investigate whether this resulted in the generation of cell pools with enhanced productivity characteristics as compared to ...